![]() |
|
|
RF Bruns, GH Lu and TA Pugsley
[3H]NECA (1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-D- ribofuronamide) is known to bind to both the A1 and A2 subtypes of adenosine receptor in rat striatal membranes. In order to study the putative A2 component of [3H]NECA binding, we examined several compounds for the ability to selectively eliminate the A1 component of binding; N6-cyclopentyladenosine was found to give the most satisfactory results. Binding of [3H]NECA in the presence of 50 nM N6- cyclopentyladenosine was characterized. The rank order of potency for inhibition of [3H]NECA binding was NECA much greater than 2- chloroadenosine greater than N6-[(R)-1-methyl-2-phenyl-ethyl]adenosine (R-PIA) greater than N6-cyclohexyladenosine greater than S-PIA, indicating that binding was to an A2 adenosine receptor. When affinities of compounds in [3H]NECA binding to A2 receptors were compared to their affinities in [3H]N6-cyclohexyladenosine binding to A1 receptors, N6-cyclopentyladenosine was the most A1-sensitive agonist (A1 Ki, 0.59 nM; A2 Ki, 460 nM; Ki ratio, 780), whereas the selective coronary vasodilator 2-(phenylamino)adenosine was the most A2-selective agonist (A1, 560 nM; A2, 120 nM; ratio, 0.21). The antagonist 8- cyclopentyltheophylline had considerable A1 selectivity (A1, 11 nM; A2, 1400 nM; ratio, 130), whereas alloxazine had slight A2 selectivity (A1, 5200 nM; A2, 2700; ratio, 0.52). [3H]NECA binding to A2 receptors was highest in striatum but was detectable at much lower levels in each of seven other brain areas. The regional distribution of [3H]NECA binding and the affinities of adenosine agonists and antagonists for inhibition of binding indicate that the site labeled by [3H]NECA belongs to the high affinity, or A2a, subclass of A2 receptor.
This article has been cited by other articles:
![]() |
V. L. Kolachala, R. Bajaj, M. Chalasani, and S. V. Sitaraman Purinergic receptors in gastrointestinal inflammation Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G401 - G410. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Ansari, A. Nadeem, M. A. H. Talukder, S. Sakhalkar, and S. J. Mustafa Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H719 - H725. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Scislo and D. S. O'Leary Adenosine receptors located in the NTS contribute to renal sympathoinhibition during hypotensive phase of severe hemorrhage in anesthetized rats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2453 - H2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Guinzberg, D. Cortes, A. Diaz-Cruz, H. Riveros-Rosas, R. Villalobos-Molina, and E. Pina Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E940 - E951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Adair Growth regulation of the vascular system: an emerging role for adenosine Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. E. Hartwick, M. R. Lalonde, S. Barnes, and W. H. Baldridge Adenosine A1-Receptor Modulation of Glutamate-Induced Calcium Influx in Rat Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3740 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm and P. Svenningsson Adenosine-dopamine interactions: Development of a concept and some comments on therapeutic possibilities Neurology, December 9, 2003; 61(90116): S5 - 9. [Abstract] [Full Text] |
||||
![]() |
B. Michaelidis, N. S. Loumbourdis, and E. Kapaki Analysis of monoamines, adenosine and GABA in tissues of the land snail Helix lucorum and lizard Agama stellio stellio during hibernation J. Exp. Biol., April 15, 2002; 205(8): 1135 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Allegrucci, L. Liguori, and A. Minelli Stimulation by N6-Cyclopentyladenosine of A1 Adenosine Receptors, Coupled to G{{alpha}}i2 Protein Subunit, Has a Capacitative Effect on Human Spermatozoa Biol Reprod, June 1, 2001; 64(6): 1653 - 1659. [Abstract] [Full Text] |
||||
![]() |
A. C. Ngai, E. F. Coyne, J. R. Meno, G. A. West, and H. R. Winn Receptor subtypes mediating adenosine-induced dilation of cerebral arterioles Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2329 - H2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Beukers, H. den Dulk, E. W. van Tilburg, J. Brouwer, and A. P. Ijzerman Why Are A2B Receptors Low-Affinity Adenosine Receptors? Mutation of Asn273 to Tyr Increases Affinity of Human A2B Receptor for 2-(1-Hexynyl)adenosine Mol. Pharmacol., April 13, 2001; 58(6): 1349 - 1356. [Abstract] [Full Text] |
||||
![]() |
E. Arrigoni, D. G. Rainnie, R. W. McCarley, and R. W. Greene Adenosine-Mediated Presynaptic Modulation of Glutamatergic Transmission in the Laterodorsal Tegmentum J. Neurosci., February 1, 2001; 21(3): 1076 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Olanrewaju, W. Qin, I. Feoktistov, J.-L. Scemama, and S. J. Mustafa Adenosine A2A and A2B receptors in cultured human and porcine coronary artery endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H650 - H656. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Salvatore, S. L. Tilley, A. M. Latour, D. S. Fletcher, B. H. Koller, and M. A. Jacobson Disruption of the A3 Adenosine Receptor Gene in Mice and Its Effect on Stimulated Inflammatory Cells J. Biol. Chem., February 11, 2000; 275(6): 4429 - 4434. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Shin, Y. W. Shin, and K. W. Hong Role of adenosine A2B receptors in vasodilation of rat pial artery and cerebral blood flow autoregulation Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H339 - H344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Peyot, A.-P. Gadeau, F. Dandre, I. Belloc, F. Dupuch, and C. Desgranges Extracellular Adenosine Induces Apoptosis of Human Arterial Smooth Muscle Cells via A2b-Purinoceptor Circ. Res., January 7, 2000; 86(1): 76 - 85. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Hein, L. Belardinelli, and L. Kuo Adenosine A2A Receptors Mediate Coronary Microvascular Dilation to Adenosine: Role of Nitric Oxide and ATP-Sensitive Potassium Channels J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 655 - 664. [Abstract] [Full Text] |
||||
![]() |
J. Xaus, A. F. Valledor, M. Cardo, L. Marques, J. Beleta, J. M. Palacios, and A. Celada Adenosine Inhibits Macrophage Colony-Stimulating Factor-Dependent Proliferation of Macrophages Through the Induction of p27kip-1 Expression J. Immunol., October 15, 1999; 163(8): 4140 - 4149. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Watson, S. E. White, J. H. Homan, L. Fraher, J. F. Brien, and A. D. Bocking The adenosine A1-receptor antagonist 8-CPT reverses ethanol-induced inhibition of fetal breathing movements J Appl Physiol, October 1, 1999; 87(4): 1333 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Crosson and M. Petrovich Contributions of Adenosine Receptor Activation to the Ocular Actions of Epinephrine Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2054 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Wiesner, B. G. Ugarkar, A. J. Castellino, J. Barankiewicz, D. P. Dumas, H. E. Gruber, A. C. Foster, and M. D. Erion Adenosine Kinase Inhibitors as a Novel Approach to Anticonvulsant Therapy J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1669 - 1677. [Abstract] [Full Text] |
||||
![]() |
J. Haynes Jr., B. Obiako, P. Babal, and T. Stevens 5-(N-ethylcarboxamido)adenosine desensitizes the A2b-adenosine receptor in lung circulation Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1877 - H1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grondin, P. J. Bedard, A. H. Tahar, L. Gregoire, A. Mori, and H. Kase Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys Neurology, May 1, 1999; 52(8): 1673 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Masino and T. V. Dunwiddie Temperature-Dependent Modulation of Excitatory Transmission in Hippocampal Slices Is Mediated by Extracellular Adenosine J. Neurosci., March 15, 1999; 19(6): 1932 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xaus, M. Mirabet, J. Lloberas, C. Soler, C. Lluis, R. Franco, and A. Celada IFN-{gamma} Up-Regulates the A2B Adenosine Receptor Expression in Macrophages: A Mechanism of Macrophage Deactivation J. Immunol., March 15, 1999; 162(6): 3607 - 3614. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. King, S. S. Wildman, A. Townsend-Nicholson, and G. Burnstock Antagonism of an Adenosine/ATP Receptor in Follicular Xenopus Oocytes J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1005 - 1011. [Abstract] [Full Text] |
||||
![]() |
P. Ferrari, L. Torielli, M. Ferrandi, G. Padoani, L. Duzzi, M. Florio, F. Conti, P. Melloni, L. Vesci, N. Corsico, et al. PST2238: A New Antihypertensive Compound That Antagonizes the Long-Term Pressor Effect of Ouabain J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 83 - 94. [Abstract] [Full Text] |
||||
![]() |
E. Gao, D. L. Snyder, J. Roberts, E. Friedman, G. Cai, A. Pelleg, and J. Horwitz Age-Related Decline in Beta Adrenergic and Adenosine A1 Receptor Function in the Heart Are Attenuated by Dietary Restriction J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 186 - 192. [Abstract] [Full Text] |
||||
![]() |
E. C. Mun, K. J. Tally, and J. B. Matthews Characterization and regulation of adenosine transport in T84 intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 1998; 274(2): G261 - G269. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Sawmiller, R. A. Fenton, and J. G. Dobson Jr. Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H627 - H635. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Dubey, D. G. Gillespie, Z. Mi, and E. K. Jackson Exogenous and Endogenous Adenosine Inhibits Fetal Calf Serum–Induced Growth of Rat Cardiac Fibroblasts : Role of A2B Receptors Circulation, October 21, 1997; 96(8): 2656 - 2666. [Abstract] [Full Text] |
||||
![]() |
K. Kessey and D. J. Mogul NMDA-Independent LTP by Adenosine A2 Receptor-Mediated Postsynaptic AMPA Potentiation in Hippocampus J Neurophysiol, October 1, 1997; 78(4): 1965 - 1972. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Carter Hippocampal Noradrenaline Release in Awake, Freely Moving Rats Is Regulated by Alpha-2 Adrenoceptors but Not by Adenosine Receptors J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 648 - 654. [Abstract] [Full Text] |
||||
![]() |
H. E. Shannon, M. J. Sheardown, F. P. Bymaster, D. O. Calligaro, N. W. Delapp, J. Gidda, C. H. Mitch, B. D. Sawyer, P. W. Stengel, J. S. Ward, et al. Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 884 - 894. [Abstract] [Full Text] |
||||
![]() |
H. Schoemaker, Y. Claustre, D. Fage, L. Rouquier, K. Chergui, O. Curet, A. Oblin, F. Gonon, C. Carter, J. Benavides, et al. Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 83 - 97. [Abstract] [Full Text] |
||||
![]() |
C. Ledent, J.-F. Denef, S. Cottecchia, R. Lefkowitz, J. Dumont, G. Vassart, and M. Parmentier Costimulation of Adenylyl Cyclase and Phospholipase C by a Mutant {alpha}1B-Adrenergic Receptor Transgene Promotes Malignant Transformation of Thyroid Follicular Cells Endocrinology, January 1, 1997; 138(1): 369 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Belardinelli, J. C. Shryock, J. Ruble, A. Monopoli, S. Dionisotti, E. Ongini, D. M. Dennis, and S. P. Baker Binding of the Novel Nonxanthine A2A Adenosine Receptor Antagonist [3H]SCH58261 to Coronary Artery Membranes Circ. Res., December 1, 1996; 79(6): 1153 - 1160. [Abstract] [Full Text] |
||||
![]() |
B. T. Liang and J. F. Morley A New Cyclic AMP-independent, Gs-mediated Stimulatory Mechanism via the Adenosine A2a Receptor in the Intact Cardiac Cell J. Biol. Chem., August 2, 1996; 271(31): 18678 - 18685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sidhu and C. J. Omiecinski cAMP-associated Inhibition of Phenobarbital-inducible Cytochrome P450 Gene Expression in Primary Rat Hepatocyte Cultures J. Biol. Chem., May 26, 1995; 270(21): 12762 - 12773. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Strohmeier, S. M. Reppert, W. I. Lencer, and J. L. Madara The A[IMAGE] Adenosine Receptor Mediates cAMP Responses to Adenosine Receptor Agonists in Human Intestinal Epithelia J. Biol. Chem., February 3, 1995; 270(5): 2387 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Liang and B. Haltiwanger Adenosine A2a and A2b Receptors in Cultured Fetal Chick Heart Cells : High- and Low-Affinity Coupling to Stimulation of Myocyte Contractility and cAMP Accumulation Circ. Res., February 1, 1995; 76(2): 242 - 251. [Abstract] [Full Text] |
||||
![]() |
D. Rainnie, H. Grunze, R. McCarley, and R. Greene Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal Science, February 4, 1994; 263(5147): 689 - 692. [Abstract] [PDF] |
||||
![]() |
M.R. Zarrindast, A. Vahedy, M.R. Heidari, and M. Ghazi Khansari On the mechanism(s) of morphine-induced hypothermia J Psychopharmacol, January 1, 1994; 8(4): 222 - 226. [Abstract] [PDF] |
||||
![]() |
M. J. Durcan and P. F. Morgan Time-course of the hypomotility effects of the adenosine analogues, cyclohexyladenosine and N-ethylcarboxamidoadenosine, in a holeboard test J Psychopharmacol, January 1, 1989; 3(3): 175 - 179. [Abstract] [PDF] |
||||